UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Minimizing efficacy differences between phase II and III RCTs

Nature reviews. Rheumatology, 2020-07, Vol.16 (7), p.359-360

Strand, Vibeke

2020

Volltextzugriff (PDF)

Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2017-08, Vol.31 (4), p.299-316

2017

Volltextzugriff (PDF)

Spondyloarthritis is associated with poor function and physical health-related quality of life

Journal of rheumatology, 2009-05, Vol.36 (5), p.1012-1020

2009

Volltextzugriff (PDF)

OMERACT: an international initiative to improve outcome measurement in rheumatology

Trials, 2007-11, Vol.8 (1), p.38-38, Article 38

2007

Volltextzugriff (PDF)

Evaluation and Management of the Patient With Suspected Inflammatory Spine Disease

Mayo Clinic proceedings, 2017-04, Vol.92 (4), p.555-564

2017

Volltextzugriff (PDF)

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis

Rheumatology international, 2020-07, Vol.40 (7), p.1021-1028

2020

Volltextzugriff (PDF)

Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial

Arthritis research & therapy, 2018-12, Vol.20 (1), p.269-269, Article 269

2018

Volltextzugriff (PDF)

Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study

Arthritis research & therapy, 2018-06, Vol.20 (1), p.113-113, Article 113

2018

Volltextzugriff (PDF)

Consensus on a core set of domains for psoriatic arthritis

Journal of rheumatology, 2007-05, Vol.34 (5), p.1167

2007

Volltextzugriff (PDF)

Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension

Rheumatic & musculoskeletal diseases open, 2023-03, Vol.9 (1), p.e002718

2023

Volltextzugriff (PDF)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial

Rheumatic & musculoskeletal diseases open, 2022-07, Vol.8 (2), p.e002366

2022

Volltextzugriff (PDF)

Classification and Outcome Measures for Psoriatic Arthritis

Frontiers in medicine, 2018-09, Vol.5, p.246-246

2018

Volltextzugriff (PDF)

Outcome measures in psoriatic arthritis

Journal of rheumatology, 2007-05, Vol.34 (5), p.1159

2007

Volltextzugriff (PDF)

Functional impairment measurement in psoriatic arthritis: Importance and challenges

Seminars in arthritis and rheumatism, 2018-12, Vol.48 (3), p.436-448

2018

Volltextzugriff (PDF)

Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination

Rheumatic & musculoskeletal diseases open, 2021-01, Vol.7 (1), p.e001484

2021

Volltextzugriff (PDF)

Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis

BMC rheumatology, 2018-01, Vol.2 (1), p.3-3, Article 3

2018

Volltextzugriff (PDF)

Outcome measures in psoriatic arthritis

Journal of rheumatology, 2005-11, Vol.32 (11), p.2262

2005

Volltextzugriff (PDF)

Sex- and gender-related differences in psoriatic arthritis

Nature reviews. Rheumatology, 2022-09, Vol.18 (9), p.513-526

2022

Volltextzugriff (PDF)

Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1)

Annals of the rheumatic diseases, 2017-01, Vol.76 (1), p.203-207

2017

Volltextzugriff (PDF)

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

Annals of the rheumatic diseases, 2017-04, Vol.76 (4), p.673-680

2017

Volltextzugriff (PDF)

25 years of biologic DMARDs in rheumatology

Nature reviews. Rheumatology, 2023-12, Vol.19 (12), p.761-766

2023

Volltextzugriff (PDF)

Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting

Journal of rheumatology, 2011-03, Vol.38 (3), p.540-545

2011

Volltextzugriff (PDF)

Risk of Thromboembolic Events and Associated Risk Factors, Including Treatments, in Patients with Immune-mediated Diseases

Clinical therapeutics, 2021-08, Vol.43 (8), p.1392-1407.e1

2021

Volltextzugriff (PDF)

Societal costs and patients' experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study

Annals of the rheumatic diseases, 2017-09, Vol.76 (9), p.1495-1501

2017

Volltextzugriff (PDF)

Improvements in Patient‐Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial

Arthritis care & research (2010), 2024-08, Vol.76 (8), p.1139-1148

2024

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Aktive Filter

ThemaPsoriatic Arthritis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(73)

Sprache

Englisch
(73)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(63)
Science & Technology
(63)
Rheumatology
(60)
Humans
(41)
Psoriasis
(31)
Arthritis, Psoriatic - Drug Therapy
(25)
Arthritis
(23)
Patients
(23)
Quality Of Life
(23)
Arthritis, Psoriatic - Diagnosis
(21)
Female
(17)
Severity Of Illness Index
(17)
Treatment Outcome
(17)
Male
(16)
Antirheumatic Agents - Therapeutic Use
(13)
Clinical Trials
(13)
Rheumatoid Arthritis
(13)
Dermatology
(11)
Monoclonal Antibodies
(11)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Minimizing efficacy differences between phase II and III RCTs

Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review

Spondyloarthritis is associated with poor function and physical health-related quality of life

OMERACT: an international initiative to improve outcome measurement in rheumatology

Evaluation and Management of the Patient With Suspected Inflammatory Spine Disease

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis

Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial

Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study

Consensus on a core set of domains for psoriatic arthritis

Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial

Classification and Outcome Measures for Psoriatic Arthritis

Outcome measures in psoriatic arthritis

Functional impairment measurement in psoriatic arthritis: Importance and challenges

Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination

Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis

Outcome measures in psoriatic arthritis

Sex- and gender-related differences in psoriatic arthritis

Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1)

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

25 years of biologic DMARDs in rheumatology

Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting

Risk of Thromboembolic Events and Associated Risk Factors, Including Treatments, in Patients with Immune-mediated Diseases

Societal costs and patients' experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study

Improvements in Patient‐Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial

Aktive Filter

Suchergebnisse filtern